Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherAssets,cash,totalCurrentLiabilities,totalCurrentAssets,accountsPayable,treasuryStock,otherStockholderEquity,changeToLiabilities,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,totalCashFromOperatingActivities,changeToAccountReceivables,changeToNetincome,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,gmtOffSetMilliseconds,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,priceHint,shortName,longName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,exchange,market,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,esgPopulated,tradeable,exchangeDataDelayedBy,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,country,website,maxAge,address1,industry,address2
t0,ITNS,-751834.0,0,,,191533,,191533,119404,0,-119404,-119404,,-810,,,,0,0,119404,0,310937,,191533,191533,5334085.0,1090990.0,-751834.0,906347.0,339156.0,293830.0,-6379749.0,241692.0,264.0,1090990.0,97464.0,132799.0,,,27542,129600,-307054,129600,-178994,-308594,-91015,-129600,-993526.0,en-US,US,EQUITY,False,Delayed Quote,USD,-7.1428537,0.0024 - 0.0028,0.0028,0.0,0.0,0,0,finmb_27194600,Other OTC,USD,4266525,1055355,0.0021,4.2,5.0E-4 - 0.009,-0.0063999994,-0.71111107,0.0005,0.009,-0.006,-14400000,-0.003,0.0029458334,-0.00034583337,-0.117397465,0.0028975524,-0.00029755244,4,ITONIS INC,"Itonis, Inc.",0.0026,1630526061,-0.0001999999,0.0028,0.0028,0.0024,533515,PRE,PNK,us_market,-0.10269096,324818,-0.8666667,15,America/New_York,EDT,False,False,0,0.27,,,0.009,0.0005,0.0029,0.0029,4.27M,1.06M,,,,0.00%,0.00%,,,,,,,2.31%,,,,0.00%,,,3:1,"Mar 20, 2007","Nov 29, 2011","Feb 28, 2012",0.00%,0.00%,,,,,,,,-1.39M,-0.0060,,264.0,0.0,,,0.01,-0.0,-97.58k,,Value,92653,Healthcare,3,"Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.",Laguna Hills,949-200-8887,CA,United States,http://www.itonisholdings.com,86400,22951 Mill Creek Drive,Medical Distribution,Suite A-1
t-1,ITNS,-1359487.0,0,,,-1305927,,-1306727,342630,0,-342630,-342630,,-470,,,,800,0,342630,0,-963297,,-1306727,-1306727,4960665.0,1368090.0,-1359487.0,1210989.0,8603.0,251130.0,-6571282.0,,2418.0,1368090.0,8603.0,125846.0,,,32200,20000,1199389,20000,-16393,-36393,-91015,37945,-1359487.0,en-US,US,EQUITY,False,Delayed Quote,USD,-7.1428537,0.0024 - 0.0028,0.0028,0.0,0.0,0,0,finmb_27194600,Other OTC,USD,4266525,1055355,0.0021,4.2,5.0E-4 - 0.009,-0.0063999994,-0.71111107,0.0005,0.009,-0.006,-14400000,-0.003,0.0029458334,-0.00034583337,-0.117397465,0.0028975524,-0.00029755244,4,ITONIS INC,"Itonis, Inc.",0.0026,1630526061,-0.0001999999,0.0028,0.0028,0.0024,533515,PRE,PNK,us_market,-0.10269096,324818,-0.8666667,15,America/New_York,EDT,False,False,0,0.27,,,0.009,0.0005,0.0029,0.0029,4.27M,1.06M,,,,0.00%,0.00%,,,,,,,2.31%,,,,0.00%,,,3:1,"Mar 20, 2007","Nov 29, 2011","Feb 28, 2012",0.00%,0.00%,,,,,,,,-1.39M,-0.0060,,264.0,0.0,,,0.01,-0.0,-97.58k,,Value,92653,Healthcare,3,"Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.",Laguna Hills,949-200-8887,CA,United States,http://www.itonisholdings.com,86400,22951 Mill Creek Drive,Medical Distribution,Suite A-1
t-2,ITNS,-5784.0,0,,,-54021,,-54021,27575,0,-27575,-27575,,-470,,,,0,0,27575,0,-26446,,-54021,-54021,4897608.0,34595.0,-5784.0,,28811.0,250057.0,-4997119.0,,18811.0,34595.0,28811.0,34595.0,-156330.0,-156330.0,0,20000,1199389,20000,-16393,-36393,-91015,37945,-5784.0,en-US,US,EQUITY,False,Delayed Quote,USD,-7.1428537,0.0024 - 0.0028,0.0028,0.0,0.0,0,0,finmb_27194600,Other OTC,USD,4266525,1055355,0.0021,4.2,5.0E-4 - 0.009,-0.0063999994,-0.71111107,0.0005,0.009,-0.006,-14400000,-0.003,0.0029458334,-0.00034583337,-0.117397465,0.0028975524,-0.00029755244,4,ITONIS INC,"Itonis, Inc.",0.0026,1630526061,-0.0001999999,0.0028,0.0028,0.0024,533515,PRE,PNK,us_market,-0.10269096,324818,-0.8666667,15,America/New_York,EDT,False,False,0,0.27,,,0.009,0.0005,0.0029,0.0029,4.27M,1.06M,,,,0.00%,0.00%,,,,,,,2.31%,,,,0.00%,,,3:1,"Mar 20, 2007","Nov 29, 2011","Feb 28, 2012",0.00%,0.00%,,,,,,,,-1.39M,-0.0060,,264.0,0.0,,,0.01,-0.0,-97.58k,,Value,92653,Healthcare,3,"Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.",Laguna Hills,949-200-8887,CA,United States,http://www.itonisholdings.com,86400,22951 Mill Creek Drive,Medical Distribution,Suite A-1
t-3,ITNS,-111106.0,0,,,37000,,36200,-37000,0,37000,37000,,-470,,,,800,0,-37000,0,0,,36200,36200,4822885.0,111106.0,-111106.0,20800.0,,244780.0,-5178771.0,,,111106.0,,90306.0,,,0,20000,1199389,20000,-16393,-36393,-91015,37945,,en-US,US,EQUITY,False,Delayed Quote,USD,-7.1428537,0.0024 - 0.0028,0.0028,0.0,0.0,0,0,finmb_27194600,Other OTC,USD,4266525,1055355,0.0021,4.2,5.0E-4 - 0.009,-0.0063999994,-0.71111107,0.0005,0.009,-0.006,-14400000,-0.003,0.0029458334,-0.00034583337,-0.117397465,0.0028975524,-0.00029755244,4,ITONIS INC,"Itonis, Inc.",0.0026,1630526061,-0.0001999999,0.0028,0.0028,0.0024,533515,PRE,PNK,us_market,-0.10269096,324818,-0.8666667,15,America/New_York,EDT,False,False,0,0.27,,,0.009,0.0005,0.0029,0.0029,4.27M,1.06M,,,,0.00%,0.00%,,,,,,,2.31%,,,,0.00%,,,3:1,"Mar 20, 2007","Nov 29, 2011","Feb 28, 2012",0.00%,0.00%,,,,,,,,-1.39M,-0.0060,,264.0,0.0,,,0.01,-0.0,-97.58k,,Value,92653,Healthcare,3,"Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.",Laguna Hills,949-200-8887,CA,United States,http://www.itonisholdings.com,86400,22951 Mill Creek Drive,Medical Distribution,Suite A-1
